Related Experiment Videos
Mutagen sensitivity in upper aerodigestive tract cancer: a case-control analysis
M R Spitz1, J J Fueger, S Halabi
1Department of Epidemiology, University of Texas, M.D. Anderson Cancer Center, Houston 77030.
Summary
Individuals with higher mutagen sensitivity, indicating lower DNA repair capability, face increased risk for upper aerodigestive tract cancers. This susceptibility, combined with heavy smoking or alcohol use, significantly elevates cancer risk.
Area of Science:
- Genetics and Cancer Epidemiology
- Molecular Toxicology
- Cancer Etiology
Background:
- Interindividual variability in DNA repair capacity influences susceptibility to carcinogens.
- Chromosomal breakage assays offer an indirect measure of DNA repair efficiency.
- Upper aerodigestive tract cancers are linked to environmental exposures, but individual susceptibility varies.
Purpose of the Study:
- To assess the association between mutagen sensitivity and the risk of upper aerodigestive tract cancers.
- To investigate the combined effects of mutagen sensitivity, smoking, and alcohol consumption on cancer risk.
Main Methods:
- A case-control study involving 108 upper aerodigestive tract cancer patients and 108 matched controls.
- Utilized a cytogenetic assay to measure in vitro mutagen sensitivity (chromosomal breakage).
- Multivariate and stratified analyses were performed to evaluate risk factors and their interactions.
Main Results:
- Sixty-nine percent of cases were mutagen sensitive compared to 44% of controls.
- Mutagen sensitivity (OR=2.5), heavy smoking (OR=4.8), and heavy alcohol consumption (OR=3.1) were significant risk factors.
- Synergistic effects were observed for smoking and mutagen sensitivity (OR=23.0) and alcohol and mutagen sensitivity (OR=5.8).
Conclusions:
- Mutagen sensitivity is a significant risk factor for upper aerodigestive tract cancers.
- Individual susceptibility, particularly DNA repair capability, plays a crucial role in cancer risk.
- Understanding interindividual differences is vital for comprehensive cancer risk assessment, even with known exposures.